Cargando…
Sunitinib-Induced Adrenal Crisis in a Patient with Pre-Existing Immunotherapy-Related Hypopituitarism
Sunitinib is a tyrosine kinase inhibitor that is frequently used in the treatment of metastatic renal cell carcinoma (mRCC). As a multikinase inhibitor, numerous off-target side effects of this medication are widely recognized. More recently, endocrine side effects, including hypoadrenalism, are bec...
Autores principales: | Javaid, Anadil, Mathai, Jared, Song, David, Brown, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832234/ https://www.ncbi.nlm.nih.gov/pubmed/35221962 http://dx.doi.org/10.1159/000521206 |
Ejemplares similares
-
Adrenal Crisis Secondary to COVID-19 Vaccination in a Patient With Hypopituitarism
por: Markovic, Nikolina, et al.
Publicado: (2022) -
PMON35 An Unusual Case of Sporadic Congenital Hypopituitarism Presenting With Micropenis and Infantile Adrenal Crisis
por: Wojeck, Brian, et al.
Publicado: (2022) -
Addisonian Crisis after Missed Diagnosis of Posttraumatic Hypopituitarism
por: Streetz-van der Werf, Christine, et al.
Publicado: (2015) -
Loperamide-induced hypopituitarism
por: Napier, Catherine, et al.
Publicado: (2016) -
RF25 | PMON95 Unique Case of Combined Presentation of Myxedema Coma and Adrenal Crisis in a Patient With Hypopituitarism or Post Sheehan's Syndrome
por: Fredrick, Jason, et al.
Publicado: (2022)